Insider · CIK 0001563572
William J Chase
Files at NTLA (Intellia Therapeutics, Inc.), GRAL (GRAIL, Inc.). First filing Aug 22, 2025, latest Aug 22, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | NTLAbuy Intellia Therapeutics, Inc. | $1.0M 100,000 shares | +288% | +63% from low-55% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +213 | $97.44 | $21k | 36,803 | Jan 16, 2026 |
| Oct 15, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +275 | $75.52 | $21k | 36,590 | Oct 16, 2025 |
| Aug 20, 2025 | NTLA Intellia Therapeutics, Inc. | POpen-market purchase Common Stock | +100,000 | $10.03 | $1.0M | 134,693 | Aug 22, 2025 |
| Jul 15, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +533 | $38.53 | $21k | 36,315 | Jul 17, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 34,693 | Jun 13, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 13, 2025 |
| May 29, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +6,082 | $41.10 | $250k | 35,782 | May 30, 2025 |
| Apr 15, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +784 | $25.94 | $20k | 29,700 | Apr 16, 2025 |
| Jan 15, 2025 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +1,182 | $17.58 | $21k | 28,916 | Jan 16, 2025 |
| Oct 30, 2024 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +210 | $13.62 | $2,860 | 27,734 | Nov 1, 2024 |
| Oct 15, 2024 | GRAL GRAIL, Inc. | AGrant or award Common Stock | +1,054 | $14.01 | $15k | 27,524 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.